YUTIQ
These highlights do not include all the information needed to use YUTIQ safely and effectively. See full prescribing information for YUTIQ. YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg, for intravitreal injection Initial U.S. Approval: 1963
Approved
Approval ID
43ba66d9-653d-48b9-9914-b0a50b68b79a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 13, 2023
Manufacturers
FDA
EyePoint Pharmaceuticals, Inc
DUNS: 968003785
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fluocinolone acetonide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71879-136
Application NumberNDA210331
Product Classification
M
Marketing Category
C73594
G
Generic Name
fluocinolone acetonide
Product Specifications
Route of AdministrationINTRAOCULAR
Effective DateDecember 13, 2023
FDA Product Classification
INGREDIENTS (3)
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
FLUOCINOLONE ACETONIDEActive
Quantity: 0.18 mg in 1 1
Code: 0CD5FD6S2M
Classification: ACTIB